Effects of tobacco smoke on the gene expression of the Cyp1a, Cyp2b, Cyp2e, and Cyp3a subfamilies in mouse liver and lung: Relation to single strand breaks of DNA

Toxicology and Applied Pharmacology

Volumn 148, Issue 2, 1998, Pages 195-204

  Villard, Pierre Henri ^a   Seree, Eric M ^a   Re, Jean Luc ^a   De Meo, Michel ^a   Barra, Yves ^a   Attolini, Laurence ^a   Dumenil, Gerard ^a   Catalin, Jacques ^a   Durand, Alain ^a   Lacarelle, Bruno ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; PROPYLENE GLYCOL; TOBACCO SMOKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DNA DAMAGE; ENZYME INHIBITION; GENE EXPRESSION REGULATION; LIVER; LUNG ALVEOLUS CELL; LUNG CANCER; LUNG CARCINOGENESIS; LUNG PARENCHYMA; MOUSE; NONHUMAN; RISK FACTOR;

ANIMALIA; MAMMALIA; NICOTIANA TABACUM; STAPHYLOCOCCUS PHAGE 3A;

EID: 0032004932     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8332     Document Type: Article

References (50)

1. Agarwal R., Jugert F. K., Khan S. G., Bickers D. R., Merk H. F., Mukhtar H. Evidence for multiple inducible cytochrome P450 isozymes in sencar mouse skin by pyridine. Biochem. Biophys. Res. Commun. 199:1994;1400-1406.
2. Ahmadi M., Khalaf L. F., Smith H. J., Nicholls P. J. A dapsone-induced blood dyscrasia in the mouse: Evidence for the role of an active metabolite. J. Pharm. Pharmacol. 48:1996;228-232.
3. Bradford M. M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Burke M. D., Thompson S., Elcombe C. R., Halpert J., Haaparanta T., Mayer R. T. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: A series of substrates to distinguish between different induced cytochromes P450. Biochem. Pharmacol. 34:1985;3337-3345.
5. Czervinski M., McLemore T. L., Gelboin H. V., Gonzalez F. J. Quantification of CYP2B7, CYP4B1 and CYPOR messenger RNAs in normal human lung and lung turmors. Cancer Res. 54:1994;1085-1091.
6. De Méo M., Laget M., Castegnaro M., Duménil G. Genotoxic activity of potassium permanganate in acid solution. Mutat. Res. 260:1991;295-306.
7. Fairbain D. W., Olive P. L., O'Neill K. L. The comet assay: A comprehensive review. Mutat. Res. 339:1995;37-59.
8. Garro A. J., Lieber C. S. Alcohol and cancer. Annu. Rev. Pharmacol. Toxicol. 30:1990;219-249.
9. Gebremichael A., Chang A. M., Buckpitt A. R., Plopper C. G., Pinkerton K. E. Postnatal development of cytochrome P4501A1 and 2B1 in rat lung and liver: effect of age and diluted sidestream cigarette smoke. Toxicol. Appl. Pharmacol. 135:1995;246-253.
10. Gonzalez F. J., Gelboin H. V. Role of humans cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab. Rev. 26:1994;165-183.
11. Guengerich F. P., Kim D. H., Iwasaki M. Role of human cytochrome P450IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4:1991;168-179.
12. Guengerich F. P. Metabolic activation of carcinogens. Pharmacol. Ther. 54:1992;17-61.
13. Guengerich F. P., Shimada T., Yun C. H., Yamazaki H., Raney K. D., Thier R., Coles B., Harris T. M. Interactions of ingested food, beverage and tobacco components involving human cytochrome P450 1A2, 2A6, 2E1 and 3A4 enzymes. Environ. Health Perspec. 102:1994;49-53.
14. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Tobacco Smoking. 1986;IARC, Lyon.
15. Kawamoto T., Yoshikawa M., Matsuno K., Kayama F., Oyama T., Arashidani K., Kodama Y. Effect of side stream cigarette smoke on the hepatic cytochromes P450. Arch. Environ. Contam. Toxicol. 25:1993;255-259.
16. Knodell R. G., Browne D. G., Gwozdz G. P., Brian W. R., Guengerich F. P. Differential inhibition of individual human liver cytochromes P450 by cimetidine. Gastroenterology. 101:1991;1680-1691.
17. Koop D. R., Tierney D. J. Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1. Bioessays. 12:1990;429-435.
18. Longo V., Ingelman-Sundberg M. Acetone dependent regulation of cytochromes P4502E1 and P4502B1 in rat nasal mucosa. Biochem. Pharmacol. 46:1993;1945-1951.
19. McLemore T. L., Adelberg S., Liu M. C., McMahon N. A., Yu S. J., Hubbard W. C., Czervinski M., Wood T. G., Storeng R., Lubet R. A., Eggleston J. C., Boyd M. R., Hines R. N. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J. Natl. Cancer Inst. 82:1990;1333-1339.
20. Mc Kelvey-Martin V. J., Green M. H. L., Schmezer P. S., Pool-Zobel B. L., De Méo M. P., Collins A. The single cell gel electrophoresis assay (comet assay): An European review. Mutat. Res. 288:1993;47-63.
21. Murray G. I., Barnes T. S., Sewell H. F., Ewen S. W. B., Melvin W. T., Burke M. D. The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissue with monoclonal antibody to human cytochrome P-450. Br. J. Clin. Pharmacol. 25:1988;465-475.
22. Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochemistry. 55:1953;416-421.
23. Nelson D. R., Kamataki T., Waxman D. J., Guengerich F. P., Estabrook R. W., Feyereisen R., Gonzalez F. J., Coon M. J., Gonzalus I. C., Gotoh O., Okuda K., Nebert D. W. The P450 super family: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nommenclature. DNA Cell Biol. 12:1993;1-51.
24. Nemoto N., Sakurai J. Glucocorticoid and sex hormones as activating or modulating factors for expression of Cyp2b-9 and Cyp2b-10 in the mouse liver and hepatocytes. Arch. Biochem. Biophys. 319:1995;286-292.
25. Olive P. L., Banath J. P., Durand R. E. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the Comet assay. Radiat. Res. 122:1990;86-94.
26. Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239:1964;2370-2378.
27. Persson J. O., Terelius Y., Ingelman-Sundberg M. Cytochrome P450 dependent formation of reactive oxygen radicals: isozyme-specific inhibition of P450-mediated reduction of oxygen and carbon tetrachloride. Xenobiotica. 20:1990;887-900.
28. Peter R., Bocker R., Beaune P. H., Iwasaki M., Guengerich F. P., Yang C. S. Hydroxylation of chlorzoxazone as a specific probe for human liver P450 IIE1. Chem. Res. Toxicol. 3:1990;566-573.
29. Pinkerton K. E., Peake J. L., Espiritu I., Goldsmith M., Witschi H. P. Quantitative histology and cytochrome P450 immunocytochemistry of the lung parenchyma following six months exposure of strain A/J mice to cigarette sidestream smoke. Inhal. Toxicol. 8:1996;927-945.
30. Sagami I., Kikuchi H., Ikawa S., Watanabe M. Characterization of hamster CYP1A1 gene. Inducible expression and negative regulation. J. Biochem. 116:1994;801-810.
31. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory, Cold Spring Harbor.
32. Shen Z., Wells R. L., Liu J., Elkind M. M. Identification of a cytochrome P450 gene by reverse transcription PCR using degenerate primers containing inosine. Proc. Natl. Acad. Sci. USA. 90:1993;11483-11487.
33. Singh N. P., McCoy M. T., Tice R. R., Schneider E. L. A simple technique for quantification of low levels DNA damage in individual cells. Exp. Cell Res. 175:1988;184-191.
34. Singh N. P., Stephzns R. E., Schneider E. L. Modifications of the alkaline microgel electrophoresis for sensitive detection of DNA damage. Int. J. Radiat. Biol. 66:1994;23-28.
35. Song B. J., Gelboin H. V., Park S. S. Monoclonal antibody-directed radioimmunoassay detects cytochrome P450 in human placenta and lymphocytes. Science. 228:1985;490-492.
36. Song B. J., Veech R. L., Saenger P. Cytochrome P450IIE1 is elevated in lymphocytes from poorly controlled insulin-dependent diabetics. J. Clin. Endocr. Metab. 71:1990;1036-1040.
37. Speit G., Hanelt S., Helbig R., Seidel A., Hartmann A. Detection of DNA effects in human cells with the comet assay and their relevants for mutagenesis. Toxicol. Lett. 88:1996;91-98.
38. Spencer J. P. E., Jenner A., Chimel K., Aruoma O. I., Cross C. E., Wu R., Halliwell B. DNA damage in human respiratory tract epithelial cells: Damage by gas phase cigarette smoke apparently involves attack by reactive nitrogen species in addition to oxygen radicals. FEBS Lett. 375:1995;179-182.
39. Swanny A., Morton R. F., Lee L. Y. Acute effect of cigarette smoke on breathing is attenued by chronic smoking in rats. J. Appl. Physiol. 74:1983;333-338.
40. Thomsen M. S., Loft S., Roberts D. W., Poulsen H. E. Cytochrome P4502E1 inhibition by propylene glycol prevents acetaminophen (paracetamol) hepatotoxicity in mice without cytochrome P4501A2 inhibition. Pharmacol. Toxicol. 76:1995;395-399.
41. Tuo J., Loft S., Thomsen M. S., Poulsen H. E. Benzene-induced genotoxicity in mice in vivo detected by the alcaline comet assay: Reduction by CYP2E1 inhibition. Mutat. Res. 368:1996;213-219.
42. Turner J. A., McNicol M. W., Sillett R. W. Distribution of carboxyhemoglobin concentrations in smokers and non-smokers. Thorax. 41:1986;25-27.
43. Uematsu F., Kikuchi R., Motomiya M., Abe T., Ishioka C., Kanamaru R., Sagami I., Watanabe R. Human cytochrome P450 IIE1 gene: Dra I polymorphism and susceptibility to cancer. Tohoku J. Exp. Med. 168:1992;113-117.
44. Van der Hoven T. A., Coon M. J. Preparation and properties of partially purified cytochrome P450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P450 reductase from rabbit liver microsomes. J. Biol. Chem. 249:1974;6302-6310.
45. Vignoli L., Cristau B., Defretin J. P., Vignoli R. Observations on the use of reactive tubers of the Draeger type for the determination of blood carbon monoxide. Arch. Mal. Prof. 21:1960;432-438.
46. Villard P. H., Sérée E. M., Lacarelle B., Théréné-Fénoglio M. C., Barra Y., Attolini L., Bruguerole B., Durand A., Catalin J. Effect of cigarette smoke on hepatic and pulmonary cytochromes P450 in mouse: Evidence for CYP2E1 induction in lung. Biochem. Biophys. Res. Commun. 202:1994;1731-1737.
47. Waxman D. J., Azaroff L. Phenobarbital induction of cytochrome P450 gene expression. Biochem. J. 281:1992;577-592.
48. Wei M. X., Tamiya T., Chase M., Boviatsis E. J., Tchang T. K. H., Kowall N. N., Hochberg F. H., Waxman D. J., Breakefield X. O., Chiocca E. A. Experimental tumor therapy, in mice using the cyclophosphamide activating cytochrome P450 2B1 gene. Hum. Gene Ther. 5:1994;969-978.
49. Wheeler C. W., Whrighton S. A., Guenthner T. M. Detection of human lung cytochromes P450 that are immunochmically related to cytochrome P450IIE1 and cytochrome P450IIIA. Biochem. Pharmacol. 44:1992;183-186.
50. Yamazoe Y., Kato R. Activation of chemical carcinogens. Cytochrome P450. 1993;Kodansha/Weinheim, Tokyo. p. 159-170.